CHMP assessment report - European Medicines Agency€¦ · to risankizumab at entry of Part B in...
If you can't read please download the document
CHMP assessment report - European Medicines Agency€¦ · to risankizumab at entry of Part B in Study M16 -010 and received risankizumab in Study M15-997 . ... complete quality data,